Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,750 | 1 | 92.2% |
| Food and Beverage | $147.58 | 2 | 7.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bard Peripheral Vascular, Inc. | $1,750 | 1 | $0 (2024) |
| Progenics Pharmaceuticals, Inc. | $147.58 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,750 | 1 | Bard Peripheral Vascular, Inc. ($1,750) |
| 2023 | $147.58 | 2 | Progenics Pharmaceuticals, Inc. ($147.58) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/01/2024 | Bard Peripheral Vascular, Inc. | EnCor (Device) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: Vascular/Oncology | ||||||
| 03/09/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $114.29 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 03/01/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $33.29 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 65 | 6,257 | 6,401 | $756,459 | $175,564 |
| 2022 | 64 | 5,893 | 6,028 | $728,600 | $171,331 |
| 2021 | 62 | 5,499 | 5,653 | $723,833 | $176,248 |
| 2020 | 60 | 5,024 | 5,209 | $631,214 | $149,847 |
All Medicare Procedures & Services
251 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Facility | 2023 | 961 | 961 | $120,125 | $35,321 | 29.4% |
| 77063 | Screening 3d breast mammography | Facility | 2023 | 953 | 953 | $90,535 | $27,831 | 30.7% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2023 | 175 | 181 | $49,413 | $12,495 | 25.3% |
| 70450 | Ct scan head or brain without contrast | Facility | 2023 | 240 | 246 | $46,248 | $7,356 | 15.9% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2023 | 97 | 97 | $25,220 | $6,344 | 25.2% |
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 139 | 140 | $31,500 | $5,351 | 17.0% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 74 | 75 | $14,250 | $5,093 | 35.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2023 | 496 | 496 | $28,768 | $4,726 | 16.4% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 100 | 100 | $24,000 | $4,282 | 17.8% |
| 72125 | Ct scan of upper spine without contrast | Facility | 2023 | 113 | 114 | $25,650 | $4,139 | 16.1% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 497 | 518 | $24,864 | $4,063 | 16.3% |
| 70496 | Ct scan of blood vessels of head with contrast | Facility | 2023 | 54 | 54 | $14,904 | $3,476 | 23.3% |
| 70498 | Ct scan of blood vessels of neck with contrast | Facility | 2023 | 52 | 52 | $14,352 | $3,214 | 22.4% |
| 70553 | Mri scan of brain before and after contrast | Facility | 2023 | 36 | 37 | $17,982 | $3,132 | 17.4% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2023 | 102 | 111 | $13,875 | $3,126 | 22.5% |
| 70551 | Mri scan of brain without contrast | Facility | 2023 | 53 | 54 | $14,958 | $2,809 | 18.8% |
| 72197 | Mri scan of pelvis before and after contrast | Facility | 2023 | 35 | 35 | $9,205 | $2,797 | 30.4% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2023 | 102 | 105 | $11,235 | $2,563 | 22.8% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Facility | 2023 | 30 | 31 | $8,711 | $2,559 | 29.4% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2023 | 115 | 118 | $11,210 | $2,517 | 22.5% |
| 19083 | Biopsy of breast and placement of locating device using ultrasound, first growth | Facility | 2023 | 19 | 19 | $9,842 | $2,242 | 22.8% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Facility | 2023 | 42 | 42 | $9,450 | $2,223 | 23.5% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 274 | 308 | $11,088 | $2,119 | 19.1% |
| 77049 | Mri scan of both breasts | Facility | 2023 | 25 | 25 | $9,125 | $2,089 | 22.9% |
| 72148 | Mri scan of lower spinal canal without contrast | Facility | 2023 | 33 | 33 | $9,141 | $1,754 | 19.2% |
About Dr. Robert Faberman, M.D
Dr. Robert Faberman, M.D is a Diagnostic Radiology healthcare provider based in Holyoke, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528008067.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Faberman, M.D has received a total of $1,898 in payments from pharmaceutical and medical device companies, with $1,750 received in 2024. These payments were reported across 3 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($1,750).
As a Medicare-enrolled provider, Faberman has provided services to 22,673 Medicare beneficiaries, totaling 23,291 services with total Medicare billing of $672,990. Data is available for 4 years (2020–2023), covering 251 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Other Specialties Diagnostic Radiology
- Location Holyoke, MA
- Active Since 06/06/2006
- Last Updated 10/31/2025
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1528008067
Products in Payments
- EnCor (Device) $1,750
- PYLARIFY (Drug) $147.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.